Olympiad Research LP Buys Shares of 8,636 Bath & Body Works, Inc. $BBWI

Olympiad Research LP purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 8,636 shares of the company’s stock, valued at approximately $259,000.

Other institutional investors also recently modified their holdings of the company. Parkside Financial Bank & Trust increased its position in shares of Bath & Body Works by 24.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after buying an additional 364 shares during the period. Parallel Advisors LLC grew its holdings in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after acquiring an additional 481 shares during the period. Natixis Advisors LLC raised its position in shares of Bath & Body Works by 0.7% in the 1st quarter. Natixis Advisors LLC now owns 90,089 shares of the company’s stock worth $2,732,000 after acquiring an additional 629 shares in the last quarter. 1834 Investment Advisors Co. lifted its stake in shares of Bath & Body Works by 4.9% in the 1st quarter. 1834 Investment Advisors Co. now owns 16,736 shares of the company’s stock valued at $507,000 after purchasing an additional 779 shares during the period. Finally, Geneos Wealth Management Inc. boosted its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Analyst Ratings Changes

BBWI has been the topic of several recent analyst reports. Wall Street Zen lowered Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Citigroup dropped their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Tuesday, August 19th. Morgan Stanley increased their target price on shares of Bath & Body Works from $40.00 to $43.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Jefferies Financial Group dropped their price objective on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a report on Monday, October 13th. Finally, Barclays reduced their target price on Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a research note on Monday, October 20th. Ten analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $38.18.

Bath & Body Works Trading Down 1.7%

BBWI opened at $22.03 on Friday. The company’s fifty day moving average price is $25.65 and its two-hundred day moving average price is $28.61. Bath & Body Works, Inc. has a 1-year low of $21.71 and a 1-year high of $41.87. The company has a market cap of $4.54 billion, a price-to-earnings ratio of 6.54, a PEG ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.55 billion. During the same period last year, the company earned $0.37 earnings per share. The business’s revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s payout ratio is currently 23.74%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.